Ligand (LGND), Glaxo (GSK) Receive FDA Approval for PROMACTA in HCV Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/15/2026

1. IBM
2. SPY
3. LCID
4. JPM
5. ERAS
6. BAC
7. TREX
8. AAPL
9. WFC
10. ORCL

Go back to Ligand (LGND), Glaxo (GSK) Receive FDA Approval for PROMACTA in HCV Patients

Ligand Pharma (LGND) shares resume trading; shares up ~8%

November 19, 2012 9:45 AM EST

Ligand Pharma (NASDAQ: LGND) shares resume trading. The stock is up 9 percent at the start.... More

Ligand Pharmaceuticals (LGND) halted, news pending

November 19, 2012 8:56 AM EST

Ligand Pharmaceuticals (Nasdaq: LGND) halted, news pending... More